YU46001B - Postupak za dobijanje novih peptida - Google Patents

Postupak za dobijanje novih peptida

Info

Publication number
YU46001B
YU46001B YU34586A YU34586A YU46001B YU 46001 B YU46001 B YU 46001B YU 34586 A YU34586 A YU 34586A YU 34586 A YU34586 A YU 34586A YU 46001 B YU46001 B YU 46001B
Authority
YU
Yugoslavia
Prior art keywords
procedure
obtaining new
insulin
new peptides
charge
Prior art date
Application number
YU34586A
Other languages
English (en)
Other versions
YU34586A (en
Inventor
J. Markussen
Original Assignee
Novo Industri A/S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri A/S. filed Critical Novo Industri A/S.
Publication of YU34586A publication Critical patent/YU34586A/xx
Publication of YU46001B publication Critical patent/YU46001B/sh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575Hormones
    • C07K14/62Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

POSTUPAK ZA DOBIJANJE NOVIH PEPTIDA, opste formule I gde slova A i B sledstveno oznakama u zagradama, oznacavaju delove peptida iz A- i B-Lanca, odnosno, oznaceni oznakama u zagradama, radikali E1, E2, E3 i E4 su Glu ili Gln ili ostatak neutralne amino kiseline, koji moze biti kodiran pomocu nukleotidnih nizova, X predstavlja L-trionin, L-arginin ili L-Lizin ostatak, Y i Z su isti ili razliciti i svaki od njih predstavlja ostatak amino kiseline, gde bilo koja strana lanca moze biti alkilirana i gde bilo koja strana lanca hidroksi grupe, moze biti alkilirana, m je 0, a n je 0 ili 1, s tim sto m i n mogu imati jednake ili razlicite vrednosti, i R predstavlja amido ili ester ostatak kojim se blokira C-pozicija karboksilne grupe B-Lanca, uz uslov da nisu svi od E1, E2, E3 glutamik ostaci kiseline, kad je X ostatak triionina, ili kad je E1, E2, E3 ostatak glutamik kiseline, a X je ostatak triionina, ili kad je E1, E2, E3 ostatak glutamik kiseline, a X je ostatak triionina, grupa iz formule -Ym-Zn-R predstavlja -NH2,Arg-NH2,Arg-NH2,-Arg-Arg-NH2, Arg-Arg-Nh2,-Arg-Lys-NH2,-Dap-Dap-NH2,-Lys-(Lau)-NH2,-Lys,Arg-NH2, -Lys-Lys-NH2, -Orn-NH2 ili -Orn-Orn-NH2, s tim sto je katalizator tripsin ili enzim tipa tripsina, naznacen time sto se vrsi transpeptidacija svinjskog insulina ili jedinjenja opste formule II: B(1-12)-E3-B(14-20)-E4-B(22-26)-X-B(28-29)-(Qq-R)-A(1-3)-E1-A(5-16)-E2-A(18-21) gde A i B oznacavaju fragmente A- i B-lanca oznacenih brojevima u zagradama. Q je peptidni lanac sa q aminokiselinama, q predstavlja ceo broj od 0 do 33, R je Lys ili Arg, dok je r jednako nuli ili jedan a E1, E2, E3 i E4, svaki ponaosob predstavljaju ostatak glutamik kiseline, dok X predstavlja ostatak treonina, - sa jedinjenjem opste formule III H-Ym-Zn-R gde Y i Z su isti ili razliciti i svaki od njih predstavlja ostatak amino kiseline, gde bilo koja strana lanca moze biti alkilirana i gde bilo koja strana lanca hidroksi grupe, moze biti alkilirana, gde m i n nisu isti ili razliciti, i svaki od njih predstavlja nulu ili jedan; gde R predstavlja amido ili ester ostatak kojim se blokira C-pozicija karboksilne grupe B-lanca, i gde amino grupe i hidroksi grupe bocnog lanca u Y i Z su opciono blokirane amino i hidroksi zastitnim grupama, uz koriscenje tripsina ili enzima tipa tripsina kao katalizatora, odnosno jedinjenja prema formuli IV gde E1, E2, E3, E4 i X imaju svaki napred opredeljena znacenja, sa jedinjenjem prema formuli III putem tripsina ili enzima tipa tripsina. Prijava sadrzi jos 8 zavisnih zahteva i 1 nezavisni zahtev.
YU34586A 1985-03-12 1986-03-10 Postupak za dobijanje novih peptida YU46001B (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK113585A DK113585D0 (da) 1985-03-12 1985-03-12 Nye peptider

Publications (2)

Publication Number Publication Date
YU34586A YU34586A (en) 1988-10-31
YU46001B true YU46001B (sh) 1992-12-21

Family

ID=8101410

Family Applications (1)

Application Number Title Priority Date Filing Date
YU34586A YU46001B (sh) 1985-03-12 1986-03-10 Postupak za dobijanje novih peptida

Country Status (22)

Country Link
EP (1) EP0194864B1 (sh)
JP (1) JPS61212598A (sh)
KR (1) KR930007433B1 (sh)
CN (1) CN86101489A (sh)
AT (1) ATE77391T1 (sh)
AU (1) AU612964B2 (sh)
CS (1) CS259536B2 (sh)
DD (1) DD244345A5 (sh)
DE (1) DE3685668T2 (sh)
DK (2) DK113585D0 (sh)
ES (1) ES8800276A1 (sh)
FI (1) FI861007A (sh)
GR (1) GR860687B (sh)
HU (1) HU201097B (sh)
IL (1) IL78103A0 (sh)
MY (1) MY102102A (sh)
NO (1) NO172441C (sh)
NZ (1) NZ215445A (sh)
PH (1) PH24260A (sh)
PT (1) PT82173B (sh)
YU (1) YU46001B (sh)
ZA (1) ZA861432B (sh)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK347086D0 (da) * 1986-07-21 1986-07-21 Novo Industri As Novel peptides
US5008241A (en) * 1985-03-12 1991-04-16 Novo Nordisk A/S Novel insulin peptides
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
DK437786D0 (da) * 1986-09-12 1986-09-12 Nordisk Gentofte Insulinprecursorer
ATE93238T1 (de) * 1988-07-20 1993-09-15 Novo Nordisk As Menschliche insulinanalage und zubereitungen daraus.
DE3827533A1 (de) * 1988-08-13 1990-02-15 Hoechst Ag Pharmazeutische zubereitung zur behandlung des diabetes mellitus
DE3837825A1 (de) * 1988-11-08 1990-05-10 Hoechst Ag Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
DK134189D0 (da) * 1989-03-20 1989-03-20 Nordisk Gentofte Insulinforbindelser
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
DE3936876A1 (de) * 1989-11-06 1991-05-23 Hoechst Ag Neue insulinderivate, verfahren zu deren herstellung, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
AUPP609198A0 (en) * 1998-09-22 1998-10-15 Curtin University Of Technology Use of non-peptidyl compounds for the treatment of insulin related ailments
US6933272B1 (en) 1998-09-22 2005-08-23 Erik Helmerhorst Use of non-peptidyl compounds for the treatment of insulin related ailments
DE10114178A1 (de) 2001-03-23 2002-10-10 Aventis Pharma Gmbh Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
DE10227232A1 (de) 2002-06-18 2004-01-15 Aventis Pharma Deutschland Gmbh Saure Insulinzubereitungen mit verbesserter Stabilität
ATE550041T1 (de) 2004-01-21 2012-04-15 Novo Nordisk Healthcare Ag Transglutaminase-vermittelte konjugation von peptiden
DK1969004T3 (da) 2005-12-28 2011-11-28 Novo Nordisk As Insulinsammensætninger og metode til at lave en sammensætning
DE102006031955A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
DE102006031962A1 (de) * 2006-07-11 2008-01-17 Sanofi-Aventis Deutschland Gmbh Amidiertes Insulin Glargin
CA2711749A1 (en) * 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Novel insulin derivatives having an extremely delayed time-action profile
DE102008003566A1 (de) * 2008-01-09 2009-07-16 Sanofi-Aventis Deutschland Gmbh Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
NZ586589A (en) 2008-01-09 2012-04-27 Sanofi Aventis Deutschland Novel insulin analogues having an extremely delayed time-action profile
LT2349324T (lt) 2008-10-17 2017-12-27 Sanofi-Aventis Deutschland Gmbh Insulino ir glp-1 agonisto derinys
TW201105346A (en) * 2009-07-06 2011-02-16 Sanofi Aventis Deutschland Heat-stable and vibration-stable insulin preparations
PL2498801T3 (pl) 2009-11-13 2018-08-31 Sanofi Aventis Deutschland Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
ES2534191T3 (es) 2009-11-13 2015-04-20 Sanofi-Aventis Deutschland Gmbh Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
AU2011252127B2 (en) * 2010-05-10 2014-02-20 Novo Nordisk A/S Process for the preparation of insulin-zinc complexes
HUE031181T2 (en) 2010-08-30 2017-06-28 Sanofi Aventis Deutschland Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
CN102174495A (zh) * 2011-01-20 2011-09-07 马忠仁 一种提取糜胰蛋白酶的方法
US9821032B2 (en) 2011-05-13 2017-11-21 Sanofi-Aventis Deutschland Gmbh Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
CN108079281A (zh) 2011-08-29 2018-05-29 赛诺菲-安万特德国有限公司 用于2型糖尿病患者中的血糖控制的药物组合
AR087744A1 (es) 2011-09-01 2014-04-16 Sanofi Aventis Deutschland Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
US9950039B2 (en) 2014-12-12 2018-04-24 Sanofi-Aventis Deutschland Gmbh Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh) 2015-03-13 2021-12-11 德商賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患治療
TW201705975A (zh) 2015-03-18 2017-02-16 賽諾菲阿凡提斯德意志有限公司 第2型糖尿病病患之治療

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK319780A (da) * 1980-07-24 1982-01-25 Forenede Bryggerier As Fremgangsmaade til enzymatisk udskiftning af b-30 aminosyren i insuliner
DE3326472A1 (de) * 1983-07-22 1985-02-14 Hoechst Ag, 6230 Frankfurt Neue insulin-derivate, verfahren zu deren herstellung und deren verwendung sowie pharmazeutische mittel zur behandlung des diabetes mellitus
DE3333640A1 (de) * 1983-09-17 1985-04-25 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von insulin-derivaten, deren b-kette c-terminal verlaengert ist, neue basisch modifizierte insulin-derivate diese enthaltende mittel und ihre verwendung
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat

Also Published As

Publication number Publication date
CS166686A2 (en) 1987-12-17
ZA861432B (en) 1986-11-26
ES552879A0 (es) 1987-11-01
FI861007A (fi) 1986-09-13
AU612964B2 (en) 1991-07-25
DK107086D0 (da) 1986-03-10
PT82173A (en) 1986-04-01
IL78103A0 (en) 1986-07-31
GR860687B (en) 1986-07-11
NO172441B (no) 1993-04-13
JPS61212598A (ja) 1986-09-20
DE3685668D1 (en) 1992-07-23
EP0194864A3 (en) 1989-01-11
DK158677B (da) 1990-07-02
YU34586A (en) 1988-10-31
KR930007433B1 (ko) 1993-08-10
FI861007A0 (fi) 1986-03-11
ES8800276A1 (es) 1987-11-01
KR860007288A (ko) 1986-10-10
AU5449586A (en) 1986-09-18
HU201097B (en) 1990-09-28
CS259536B2 (en) 1988-10-14
DE3685668T2 (de) 1993-01-14
ATE77391T1 (de) 1992-07-15
NZ215445A (en) 1989-07-27
PT82173B (pt) 1988-07-29
NO860920L (no) 1986-09-15
PH24260A (en) 1990-05-04
HUT41052A (en) 1987-03-30
CN86101489A (zh) 1987-01-21
DD244345A5 (de) 1987-04-01
DK158677C (da) 1990-12-31
NO172441C (no) 1993-07-21
DK107086A (da) 1986-11-07
DK113585D0 (da) 1985-03-12
MY102102A (en) 1992-03-31
EP0194864A2 (en) 1986-09-17
EP0194864B1 (en) 1992-06-17

Similar Documents

Publication Publication Date Title
YU46001B (sh) Postupak za dobijanje novih peptida
ES2061504T3 (es) Nuevos peptidos.
MY106287A (en) Acid addition salts of amidated taurine or glycine, their preparation and use
DK376187A (da) Peptider